Short interest in Esperion Therapeutics Inc (NASDAQ:ESPR) decreased during the last reporting period, falling from 33.46M to 31.25M. This put 15.9% of the company's publicly available shares short.

Short interest for Esperion Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Esperion Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 6.43M shares traded per day, it would take 4.86 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.